This was also supported by our findings that strong FAM13C expression continuously increased from benign prostate lesions (BPH and PIN) to high Gleason grade cancers, lymph node metastasis and hormone refractory cancers. The gene discussed is FAM13C; the disease is metastatic malignant neoplasm in the lymph nodes.